Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy

Tislelizumab OS benefit vs sorafenib as first line treatment for unresectable hepatocellular carcinoma

Pembro + CRT in HNSCC fails to deliver statistically significant event-free survival improvement

Lenvatinib remains standard of care for first-line therapy in advanced hepatocellular carcinoma

Hyperthermic intraperitoneal chemo for locally advanced colon cancer

Sacituzumab govitecan continues to improve OS for ET-resistant HR+/HER2-mBC, and QoL update

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan

Lasofoxifene shows promise for women with ESR1-mutated mBC

New data presented at ESMO for multi-cancer early detection

Perioperative nivolumab did not improve RFS in RCC patients at high risk for recurrence

Nirogacestat demonstrates clinically significant improvement in PFS versus placebo for progressing desmoid tumours

Scientists discover mechanism of action and an actionable inflammatory axis for air pollution induced NSCLC